Category - M&As and partnerships

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

Broad Institute and Verily partner with Microsoft to accelerate the next generation of the Terra platform for health and life science research

QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute

Pharmacogenetic and Genealogy Pioneers Merge for Historic Partnership

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe

Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads

Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing

PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets

DNASTAR Integrates Genomenon Mastermind Database for Human Variant Analysis

Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA

Varian Medical Systems Invests in COTA, Inc. to Help Drive Faster, More Accurate Data-Driven Cancer Care

Intermountain Healthcare and Sanford Health announce intent to merge

Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics

Copyright © 2026. enlighenbio LLC. All rights reserved.